Upregulation of neurotrophic factor-related gene expression in retina with experimental autoimmune uveoretinitis by intravitreal injection of tacrolimus (FK506)

British Journal of Ophthalmology

Volumn 91, Issue 11, 2007, Pages 1537-1540

  Oh i, Keiko ^a   Keino, Hiroshi ^a   Goto, Hiroshi ^a   Yamakawa, Naoyuki ^a   Takeuchi, Masaru ^a   Usui, Masahiko ^a   Iwasaki, Takuya ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DNA; ERYTHROPOIETIN RECEPTOR; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; NEUROPEPTIDE Y RECEPTOR; NEUROTROPHIC FACTOR; PROTEIN KINASE C; RETINOID BINDING PROTEIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA CELL; UVEORETINITIS;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS; NERVE GROWTH FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED LEW; RETINITIS; RNA, MESSENGER; TACROLIMUS; UP-REGULATION; UVEITIS, ANTERIOR; VITREOUS BODY;

EID: 35748958137     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.116525     Document Type: Article

References (33)

1. Kino T, Hatanaka H, Hashimoto M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 1987;40:1249-55.
2. Wong W, Venetz JP, Tolkoff-Rubin N, et al. 2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? Transplantation 2005;80:289-96.
3. Wente MN, Sauer P, Mehrabi A, et al. Review of the clinical experience with a modified release form of tacrolimus [FK506E (MR4)] in transplantation. Clin Transplant, 2006;20(Suppl 17), 80-4.
4. Butcher SP, Henshall DC, Teramura Y, et al. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci 1997;17:6939-46.
5. Furuichi Y, Noto T, Li JY, et al. Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats. Brain Res 2004;1014: 120-30.
6. Zawadzka M, Kaminska B. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells. Glia 2005;49:36-51.
7. Labrande C, Velly L, Canolle B, et al. Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: role of glutamate uptake and FK506 binding protein 12 kDa. Neuroscience 2006;137:231-9.
8. Freeman EE, Grosskreutz CL. The effects of FK506 on retinal ganglion cells after optic nerve crush. Invest Ophthalmol Vis Sci 2000;41:1111-5.
9. Caspi RR, Roberge FG, Chan CC, et al. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 1988;140:1490-5.
10. Chan CC, Caspi RR, Ni M, et al. Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun 1990;3:247-55.
11. Forrester JV, Liversidge J, Dua HS, et al. Experimental autoimmune uveoretinitis: a model system for immunointervention: a review. Curr Eye Res 1992;11(Suppl):33-40.
12. Gery I, Wiggert B, Redmond TM, et al. Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Invest Ophthalmol Vis Sci 1986;27:1296-300.
13. Caspi RR, Roberge FG, McAllister CG, et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol 1986;136:928-33.
14. Sanui H, Redmond TM, Kotake S, et al. Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP). J Exp Med 1989;169:1947-60.
15. Caspi RR, Silver PB, Chan CC, et al. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J Immunol 1996;157:2668-75.
16. Caspi RR, Sun B, Agarwal RK, et al. T cell mechanisms in experimental autoimmune uveoretinitis: susceptibility is a function of the cytokine response profile. Eye, 1997;11(Pt 2), 209-12.
17. Oh-i K, Keino H, Goto H, et al. Intravitreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in Rats. Br J Ophthalmol 2006;91:237-42.
18. Okada AA, Keino H, Fukai T, et al. Effect of type I interferon on experimental autoimmune uveoretinitis in rats. Ocul Immunol Inflamm 1998;6:215-26.
19. Littleton-Kearney MT, Ostrowski NL, Cox DA, et al. Selective estrogen receptor modulators: tissue actions and potential for CNS protection. CNS Drug Rev 2002;8:309-30.
20. Marin R, Guerra B, Alonso R, et al. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Curr Neurovasc Res 2005;2:287-301.
21. Cordey M, Pike CJ. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res 2005;1045:217-23.
22. Aydin A, Genc K, Akhisaroglu M, et al. Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury. Brain Dev 2003;25:494-8.
23. Genc S, Koroglu TF, Genc K. Erythropoietin and the nervous system. Brain Res 2004;1000:19-31.
24. Bartesaghi S, Marinovich M, Corsini E, et al. Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology 2005;26:923-8.
25. Paula-Lima AC, De Felice FG, Brito-Moreira J, et al. Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxiciry of beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology 2005;49:1140-8.
26. Cordey M, Gundimeda U, Gopalakrishna R, et al. Estrogen activates protein kinase C in neurons: role in neuroprotection. J Neurochem 2003;84:1340-8.
27. Cordey M, Pike O. Conventional protein kinase C isoforms mediate neuroprotection induced by phorbol ester and estrogen. J Neurochem 2006;96:204-17.
28. Cheng H, Wu JP, Tzenq SF. Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury. J Neurosci Res 2002;69:397-405.
29. Mark RJ, Fuson KS, Keane-Lazar K, et al. Fibroblast growth factor-8 protects cultured rat hippocampal neurons from oxidative insult. Brain Res 1999;830:88-93.
30. Wang SJ. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway. Neuroscience 2005;134:987-1000.
31. Iwasaki Y, Ichikawa Y, Igarashi O, et al. Neuroprotective actions of FK506 and cyclosporin A on motor neuron survival following neonatal axotomy. Neurol Res 2002;24:573-6.
32. Weishaupt JH, Rohde G, Polking E, et al. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004;45:1514-22.
33. Kilic U, Kilic E, Soliz J, et al. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J 2005;19:249-51.